Related Experiment Videos
Cord blood study on beta-thalassemia and hemoglobin E
S Pootrakul1, V Muang-sup, S Fucharoen
1Department of Medicine, Faculty of Medicine, Siriraj Hospital, Mahidol University, Bangkok, Thailand.
American Journal of Medical Genetics
|January 1, 1988
Summary
Early detection of hemoglobinopathies like beta-thalassemia and Hb E is possible in newborns. Analyzing red cell fragility, morphology, and hemoglobin types at birth aids in diagnosing various genetic blood disorders.
Area of Science:
- Hematology
- Medical Genetics
- Neonatology
Background:
- Hemoglobinopathies, including beta-thalassemia and Hemoglobin E (Hb E), are significant inherited blood disorders.
- Accurate diagnosis in newborns is crucial for timely management and genetic counseling.
- Distinguishing between different genetic variants (heterozygosity, homozygosity, and compound heterozygosity) can be challenging at birth.
Purpose of the Study:
- To evaluate the utility of cord blood hematologic parameters for diagnosing various hemoglobinopathies in newborns.
- To assess red cell osmotic fragility, morphology, and hemoglobin electrophoresis for identifying beta-thalassemia trait, Hb E trait, and their homozygous or compound heterozygous states.
Main Methods:
- Hematologic data, including red cell osmotic fragility, red cell morphology, and starch gel electrophoresis for hemoglobin typing, were analyzed from 18 newborn infants.
- Infants included offspring of patients with beta-thal/Hb E disease and those identified with decreased red cell osmotic fragility.
- Follow-up data were collected to confirm initial diagnoses.
Main Results:
- Hb E heterozygosity was identified in two infants with normal osmotic fragility and specific Hb E levels at birth.
- Beta-thalassemia heterozygosity was diagnosed in eleven infants based on decreased red cell osmotic fragility, microcytosis, poikilocytosis, and specific hemoglobin patterns.
- Homozygous beta-thalassemia, Hb E homozygosity, and beta-thal/Hb E disease were diagnosed in several infants based on combined hematologic findings and follow-up evaluations.
Conclusions:
- Combined analysis of red cell osmotic fragility, morphology, and starch gel electrophoresis at birth enables accurate diagnosis of beta-thalassemia trait, beta-thalassemia homozygosity, Hb E heterozygosity, Hb E homozygosity, and beta-thal/Hb E compound heterozygosity.
- These methods provide a reliable approach for early detection of significant hemoglobinopathies in the neonatal period.
- Early diagnosis facilitates appropriate clinical management and genetic counseling for affected families.